Cowen

In a note released on Wednesday, Cowen upgraded the shares of the DowDuPont Inc (NYSE: DWDP) from Market Perform to Outperform and raised the price target on the shares from $60 to $80, which suggests roughly 17 percent upside from Tuesday's closing price of $68.52. Analysts Charles Neivert and...

General Electric Company (NYSE: GE) hasn’t gotten much love from Wall Street in recent months, but its recent Baker Hughes (NYSE: BHGE) spin-off certainly is. On Monday, Cowen analyst Marc Bianchi reiterated his positive outlook for the new Baker Hughes based on improving transparency and...

Analysts at Cowen highlighted four reasons why investors should consider buying Allscripts Healthcare Solutions Inc (NASDAQ: MDRX). The firm's Charles Rhyee upgraded Allscripts' stock rating from Market Perform to Outperform with a price target raised from $13 to $16. 1. Improving...

Shares of Chipotle Mexican Grill, Inc. (NYSE: CMG) lost more than 2 percent early Friday morning after analysts at Cowen turned sour on the fast-casual restaurant chain. Analysts at Cowen now rate Chipotle a Sell, with a $250 price target, CNBC's Carl Quintanilla highlighted in a tweet. The...

Pre-open movers U.S. stock futures traded slightly higher in early pre-market trade. Data on international trade for July will be released at 8:30 a.m. ET, while US Services Purchasing Managers' Index for August will be released at 9:45 a.m. ET. The ISM non-manufacturing report for August is...

The big news for the week in the biotech space is the huge $12 billion buyout of Kite Pharma Inc (NASDAQ: KITE) by Gilead Sciences, Inc. (NASDAQ: GILD). Gilead, Kite and other biotech investors are eager to know Wall Street’s take on the big deal and what it means for the market. Related Link...

Dara Khosrowshahi, Expedia Inc (NASDAQ: EXPE)'s veteran CEO, reportedly accepted the vacant CEO position at Uber and will be leaving the online travel agency. Shares of Expedia fell more than 4 percent following the reports, which implies Expedia's investors view Khosrowshahi's...

Autodesk, Inc. (NASDAQ: ADSK) reported a second-quarter non-GAAP loss of 11 cents per share on revenues of $502 million, down 9 percent. The results were ahead of the consensus estimates, which called for a loss of 23 cents per share on revenues of $470 million. Subscription plan subscriptions...

Adamas Pharmaceuticals Inc (NASDAQ: ADMS) shares were on a tear Friday following that the FDA has approved its GOCOVRI extended release capsules for dyskinesia in patients with Parkinson's disease receiving levodopa-based therapy, with or without dopaminergic medications. At the time of...

One analyst is backtracking on his call on Dicks Sporting Goods Inc (NYSE: DKS), claiming he overestimated the company's ability to achieve guidance and maintain profitability in spite of structural and cyclical headwinds. Cowen analyst John Kernan believes the price war Dicks is currently...